Device Trial Radar · NCT07925034
PREFIX FEASIBILITY Study - PRojection & Safety Evaluation of the FIXNip Nipple Reconstruction Implant
Last checked: Nov 19, 2026Latest source record: Nov 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
5
Planned (sponsor's estimate)
Start
Nov 1, 2026
Primary completion
Feb 15, 2028
Study completion Apr 2028
Sponsor
- Lead sponsor
- FixNip LtdNot on our public-company list
- Sponsor type
- Industry
- First posted
- Nov 9, 2026
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Device feasibility
- FDA-regulated device
- Yes
- Who can join
- Female only, from 22 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a prospective, single center, controlled, open-label feasibility IDE clinical study enrolling patients with a history of breast cancer who have previously undergone total mastectomy with breast reconstruction and are seeking nipple reconstruction.
Conditions
- Breast Reconstruction After Mastectomy
Interventions
NRI implantationDevice
NRI implantation
Primary outcomes
What the sponsor says the trial is designed to measure.
- Feasibility study under an Investigational Device Exemption (IDE)Time frame: 12 months
Locations
1 site in 1 country. Site status is shown where the registry gives one.
MD Anderson
Houston, Texas · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.